- Q4 2023 bluebird bio Inc Earnings Call TranscriptMar 26, 2024$1.2 (-11.76%)Earnings
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 bluebird bio Inc Earnings Call TranscriptNov 07, 2023$3.54 (+7.27%)Earnings
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 bluebird bio Inc Earnings Call TranscriptAug 08, 2023$3.89 (+8.06%)Earnings
- bluebird bio Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- bluebird bio Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q4 2022 bluebird bio Inc Earnings Call TranscriptMar 29, 2023$3.26 (-24.54%)Earnings
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- bluebird bio Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- bluebird bio Inc Receives FDA Accelerated Approval for SKYSONA Call TranscriptSep 19, 2022
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- bluebird bio Inc Launch Call TranscriptAug 18, 2022
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- bluebird bio Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- bluebird bio Inc Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US Investor Call TranscriptApr 05, 2022
- bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- bluebird bio Inc Spotlight on bb1111 for Sickle Cell Disease Conference Call TranscriptNov 18, 2021
- bluebird bio Inc at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 16, 2021
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- bluebird bio Inc at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 11, 2021
- Q2 2021 bluebird bio Inc Earnings Call TranscriptAug 09, 2021$11.76 (-27.45%)Earnings
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- bluebird bio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- bluebird bio Inc to Provide Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program - Conference Call TranscriptMar 10, 2021
- bluebird bio Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- bluebird bio Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- bluebird bio Inc Temporary Suspension On Phase 1/2 And Phase 3 Studies Of LentiGlobin Gene Therapy For Sickle Cell Disease (bb1111) Corporate Call TranscriptFeb 16, 2021
- bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- bluebird bio Inc to Separate Oncology Business into Independent Company Conference Call TranscriptJan 11, 2021
- bluebird bio Inc ASH Data Review Conference Call TranscriptDec 08, 2020
- bluebird bio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- bluebird bio Inc at Cowen Immuno-Oncology Next Summit TranscriptNov 13, 2020
- Q3 2020 bluebird bio Inc Earnings Call TranscriptNov 04, 2020$37.9 (+7.33%)Earnings
- bluebird bio Inc at Jefferies Cell Therapy Summit TranscriptOct 06, 2020
- bluebird bio Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- bluebird bio Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2020
- bluebird bio Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 12, 2020
- bluebird bio Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- bluebird bio Inc EHA Data Review - Call TranscriptJun 12, 2020
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- bluebird bio Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- bluebird bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Q1 2020 bluebird bio Inc Earnings Call TranscriptMay 11, 2020$38.99 (+1.60%)Earnings
- bluebird bio Inc Provides Assessment of Impact of COVID-19 - Call TranscriptMar 26, 2020
- bluebird bio Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- bluebird bio Inc at Leerink Global Healthcare Conference TranscriptFeb 26, 2020
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- bluebird bio Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- bluebird bio Inc American Society of Hematology (ASH) Data Review - Call TranscriptDec 10, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa TranscriptOct 02, 2019
- bluebird bio Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- bluebird bio Inc at Citi Biotech Conference TranscriptSep 04, 2019
- bluebird bio Inc to Present New Data at the European Hematology Association (EHA) Congress Conference Call TranscriptJun 14, 2019
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- bluebird bio Inc at Jefferies Healthcare Conference TranscriptJun 04, 2019
- bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- bluebird bio Inc Analyst Day TranscriptMay 09, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean - PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY TranscriptApr 23, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day TranscriptMar 21, 2019
- bluebird bio Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- bluebird bio Inc at Cowen Health Care Conference TranscriptMar 12, 2019
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Okay, great. Good morning. I'm Eric Joseph, senior biotech analyst with JPMorgan and our next presenting company. Bluebird bio. And to take us through the story is company's CTO, Andrew Obin chain there is a Q&A session after the presentation. Just raise your hand. We'll bring a mike over to you for those who have questions. And then for those who are tuning in via webcast, feel free to submit questions as well. We'll bring them up in Q&A. So with that, Andrew, thanks for joining us.
Good morning.
Thank you, Eric, and welcome to everyone in the room and welcome to everyone on the webcast is as well. Bluebird is in a class of its own with the only company with three FDA approved gene therapies. Most recently, we added lift Kenya to that mixed with approval in December for sickle cell disease and with still of the most underserved populations in the US. And importantly, all of this puts us on a solid path to profitability in the near
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)